Gerresheimer AG (0NTI.L)
- Previous Close
60.42 - Open
62.05 - Bid --
- Ask --
- Day's Range
62.05 - 62.05 - 52 Week Range
62.05 - 62.05 - Volume
10,089 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
www.gerresheimer.com11,947
Full Time Employees
November 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0NTI.L
Performance Overview: 0NTI.L
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0NTI.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0NTI.L
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
5.86%
Return on Assets (ttm)
4.13%
Return on Equity (ttm)
9.07%
Revenue (ttm)
2B
Net Income Avi to Common (ttm)
117.08M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
106.5M
Total Debt/Equity (mrq)
76.38%
Levered Free Cash Flow (ttm)
-105.74M